Kyntra Bio, Inc. (KYNB)
6.99
-0.11
(-1.55%)
USD |
NASDAQ |
Sep 18, 16:00
6.99
0.00 (0.00%)
After-Hours: 19:19
Kyntra Bio Price : 6.99 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | 7.73 | 7.750 | 7.05 | 7.10 | 38618.00 |
| Sep 16, 2026 | 7.78 | 7.845 | 7.61 | 7.61 | 17730.00 |
| Sep 15, 2026 | 7.81 | 7.950 | 7.38 | 7.77 | 12094.00 |
| Sep 14, 2026 | 7.85 | 8.06 | 7.79 | 8.03 | 23777.00 |
| Sep 11, 2026 | 8.175 | 8.25 | 7.92 | 7.97 | 9683.00 |
| Sep 10, 2026 | 8.42 | 8.42 | 7.03 | 7.975 | 83887.00 |
| Sep 09, 2026 | 8.120 | 8.260 | 7.985 | 8.04 | 5902.00 |
| Sep 08, 2026 | 8.41 | 8.50 | 8.05 | 8.22 | 11049.00 |
| Sep 04, 2026 | 8.335 | 8.67 | 8.335 | 8.55 | 11906.00 |
| Sep 03, 2026 | 8.59 | 8.635 | 8.285 | 8.49 | 12430.00 |
| Sep 02, 2026 | 7.97 | 8.65 | 7.92 | 8.53 | 42193.00 |
| Sep 01, 2026 | 7.83 | 8.050 | 7.80 | 7.95 | 27581.00 |
| Aug 31, 2026 | 7.92 | 8.025 | 7.595 | 7.78 | 30752.00 |
| Aug 28, 2026 | 7.99 | 8.02 | 7.80 | 8.02 | 15784.00 |
| Aug 27, 2026 | 8.01 | 8.12 | 7.92 | 8.00 | 5867.00 |
| Aug 26, 2026 | 8.11 | 8.15 | 7.95 | 8.105 | 7394.00 |
| Aug 25, 2026 | 8.00 | 8.12 | 7.75 | 8.10 | 45181.00 |
| Aug 24, 2026 | 7.67 | 7.98 | 7.65 | 7.98 | 25651.00 |
| Aug 21, 2026 | 7.35 | 7.60 | 7.30 | 7.52 | 40009.00 |
| Aug 20, 2026 | 7.09 | 7.39 | 6.863 | 7.32 | 23976.00 |
| Aug 19, 2026 | 7.175 | 7.24 | 6.945 | 7.15 | 18770.00 |
| Aug 18, 2026 | 6.81 | 7.253 | 6.81 | 7.01 | 13735.00 |
| Aug 17, 2026 | 6.94 | 7.158 | 6.81 | 6.81 | 25777.00 |
| Aug 14, 2026 | 7.025 | 7.407 | 6.951 | 7.05 | 17735.00 |
| Aug 13, 2026 | 7.03 | 7.15 | 7.03 | 7.04 | 3784.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vericel Corp. | 39.96 |
| Capricor Therapeutics, Inc. | 9.07 |
| ARS Pharmaceuticals, Inc. | 4.11 |
| ACADIA Pharmaceuticals, Inc. | 27.28 |
| Alnylam Pharmaceuticals, Inc. | 239.57 |
Price Related Metrics
| PE Ratio | 0.2164 |
| PS Ratio | 6.126 |
| Earnings Yield | 462.2% |
| Market Cap | 28.30M |
| Normalized PE Ratio | 0.2089 |